

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of microtubule polymerization (GO:0031115) | 7.50550928 |
| 2 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 7.24089322 |
| 3 | mitochondrial calcium ion transport (GO:0006851) | 6.85137198 |
| 4 | establishment of endothelial barrier (GO:0061028) | 6.28037771 |
| 5 | oligosaccharide catabolic process (GO:0009313) | 5.80380083 |
| 6 | peptidyl-proline hydroxylation (GO:0019511) | 5.76081310 |
| 7 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 5.70772771 |
| 8 | protein localization to endosome (GO:0036010) | 5.28795720 |
| 9 | respiratory tube development (GO:0030323) | 5.25335767 |
| 10 | negative regulation of protein localization to plasma membrane (GO:1903077) | 5.22824791 |
| 11 | cardiovascular system development (GO:0072358) | 4.99402674 |
| 12 | endocardial cushion development (GO:0003197) | 4.95855772 |
| 13 | positive regulation of extracellular matrix organization (GO:1903055) | 4.81423596 |
| 14 | protein hydroxylation (GO:0018126) | 4.50205080 |
| 15 | protein localization to microtubule (GO:0035372) | 4.48468693 |
| 16 | pericardium development (GO:0060039) | 4.33460915 |
| 17 | endothelial cell development (GO:0001885) | 4.25245225 |
| 18 | mitochondrial calcium ion homeostasis (GO:0051560) | 4.14231839 |
| 19 | COPI coating of Golgi vesicle (GO:0048205) | 4.14206903 |
| 20 | Golgi transport vesicle coating (GO:0048200) | 4.14206903 |
| 21 | lymph vessel development (GO:0001945) | 4.07469286 |
| 22 | proteoglycan biosynthetic process (GO:0030166) | 4.00030237 |
| 23 | regulation of response to osmotic stress (GO:0047484) | 3.96038370 |
| 24 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.95648248 |
| 25 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.95648248 |
| 26 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.95225012 |
| 27 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.94281351 |
| 28 | induction of positive chemotaxis (GO:0050930) | 3.91855756 |
| 29 | glycosphingolipid catabolic process (GO:0046479) | 3.83964820 |
| 30 | hemoglobin metabolic process (GO:0020027) | 3.77340848 |
| 31 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 3.76752375 |
| 32 | negative regulation of osteoblast proliferation (GO:0033689) | 3.76451504 |
| 33 | actin filament capping (GO:0051693) | 3.75580336 |
| 34 | negative regulation of cell size (GO:0045792) | 3.73690806 |
| 35 | 4-hydroxyproline metabolic process (GO:0019471) | 3.68460137 |
| 36 | sialylation (GO:0097503) | 3.67534395 |
| 37 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.67528921 |
| 38 | establishment of apical/basal cell polarity (GO:0035089) | 3.66494230 |
| 39 | response to misfolded protein (GO:0051788) | 3.66208281 |
| 40 | lateral ventricle development (GO:0021670) | 3.65368485 |
| 41 | cellular response to ammonium ion (GO:0071242) | 3.61226644 |
| 42 | substrate-dependent cell migration (GO:0006929) | 3.61125403 |
| 43 | polarized epithelial cell differentiation (GO:0030859) | 3.60853281 |
| 44 | termination of RNA polymerase I transcription (GO:0006363) | 3.58808899 |
| 45 | negative regulation of muscle hypertrophy (GO:0014741) | 3.44047851 |
| 46 | regulation of extracellular matrix disassembly (GO:0010715) | 3.42242292 |
| 47 | regulation of lymphocyte migration (GO:2000401) | 3.41761922 |
| 48 | glycolipid catabolic process (GO:0019377) | 3.40101636 |
| 49 | maternal placenta development (GO:0001893) | 3.36475664 |
| 50 | pinocytosis (GO:0006907) | 3.36110230 |
| 51 | regulation of mitotic spindle organization (GO:0060236) | 3.33315523 |
| 52 | pre-miRNA processing (GO:0031054) | 3.32633316 |
| 53 | negative regulation of actin filament depolymerization (GO:0030835) | 3.29711197 |
| 54 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 3.28850999 |
| 55 | glucose 6-phosphate metabolic process (GO:0051156) | 3.24237019 |
| 56 | establishment of monopolar cell polarity (GO:0061162) | 3.24074394 |
| 57 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.24074394 |
| 58 | lymphangiogenesis (GO:0001946) | 3.21785749 |
| 59 | lung vasculature development (GO:0060426) | 3.21198545 |
| 60 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.19645753 |
| 61 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.16873250 |
| 62 | somatic stem cell division (GO:0048103) | 3.15421710 |
| 63 | negative regulation of microtubule polymerization or depolymerization (GO:0031111) | 3.10338819 |
| 64 | negative regulation of necroptotic process (GO:0060546) | 3.07992716 |
| 65 | regulation of exit from mitosis (GO:0007096) | 3.07276066 |
| 66 | glycoprotein biosynthetic process (GO:0009101) | 3.05527591 |
| 67 | lung morphogenesis (GO:0060425) | 3.03173971 |
| 68 | regulation of protein kinase C signaling (GO:0090036) | 3.00340785 |
| 69 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.99463154 |
| 70 | positive regulation of fibroblast migration (GO:0010763) | 2.96446593 |
| 71 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.96125873 |
| 72 | regulation of monocyte chemotaxis (GO:0090025) | 2.92604099 |
| 73 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.92207924 |
| 74 | ceramide catabolic process (GO:0046514) | 2.91002847 |
| 75 | regulation of protein localization to plasma membrane (GO:1903076) | 2.89562930 |
| 76 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.89043606 |
| 77 | establishment of epithelial cell polarity (GO:0090162) | 2.88683600 |
| 78 | regulation of monocyte differentiation (GO:0045655) | 2.88534238 |
| 79 | enteric nervous system development (GO:0048484) | 2.87635967 |
| 80 | mammary gland epithelial cell differentiation (GO:0060644) | 2.86696582 |
| 81 | response to muramyl dipeptide (GO:0032495) | 2.86624925 |
| 82 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.83044687 |
| 83 | regulation of microtubule polymerization (GO:0031113) | 2.81338748 |
| 84 | NIK/NF-kappaB signaling (GO:0038061) | 2.80909639 |
| 85 | blood vessel maturation (GO:0001955) | 2.79619389 |
| 86 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.77420155 |
| 87 | transcription from RNA polymerase I promoter (GO:0006360) | 2.76888657 |
| 88 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.71776527 |
| 89 | SMAD protein complex assembly (GO:0007183) | 2.71562578 |
| 90 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.70739740 |
| 91 | cell volume homeostasis (GO:0006884) | 2.70339878 |
| 92 | cellular hyperosmotic response (GO:0071474) | 2.69636935 |
| 93 | negative regulation of Notch signaling pathway (GO:0045746) | 2.69041688 |
| 94 | renal system development (GO:0072001) | 2.68150636 |
| 95 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66592614 |
| 96 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.66257401 |
| 97 | urinary tract smooth muscle contraction (GO:0014848) | 2.66070006 |
| 98 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.65520659 |
| 99 | leukocyte cell-cell adhesion (GO:0007159) | 2.65049348 |
| 100 | barbed-end actin filament capping (GO:0051016) | 12.1541469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.93113285 |
| 2 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.81967491 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.55556728 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.55376900 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.54264140 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.49437433 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.43155798 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.36176264 |
| 9 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.25283654 |
| 10 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.25064884 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.20970718 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.11874667 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.10153058 |
| 14 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.08778809 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07093960 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.98371380 |
| 17 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.98103062 |
| 18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.92158291 |
| 19 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.87264374 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82277992 |
| 21 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79002192 |
| 22 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.77654685 |
| 23 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.75950441 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75775728 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64515849 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61237099 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58518888 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57540761 |
| 29 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.52894723 |
| 30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.52412065 |
| 31 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.51940978 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50796437 |
| 33 | KDM2B_26808549_Chip-Seq_K562_Human | 1.50704880 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49968771 |
| 35 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.49085293 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.47136683 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45985294 |
| 38 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.45627875 |
| 39 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.45446306 |
| 40 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.44209562 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43706914 |
| 42 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.39324719 |
| 43 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.39175381 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.39130796 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38501558 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.37550907 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36191171 |
| 48 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33979559 |
| 49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33386708 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32605768 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32173926 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31924859 |
| 53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.31436433 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31422761 |
| 55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29409281 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.28240536 |
| 57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27033921 |
| 58 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.25062555 |
| 59 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23421611 |
| 60 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.19583136 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19338527 |
| 62 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.18267362 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 1.18178208 |
| 64 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17347375 |
| 65 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17342032 |
| 66 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.16864888 |
| 67 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.15260630 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14809055 |
| 69 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.14474800 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13755766 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13286495 |
| 72 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12405453 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11594407 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11233425 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10796607 |
| 76 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09481791 |
| 77 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07632101 |
| 78 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06932725 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06911033 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06096850 |
| 81 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.05684720 |
| 82 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.05169333 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04485847 |
| 84 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.04226833 |
| 85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03763412 |
| 86 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00827248 |
| 87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00791456 |
| 88 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.99466539 |
| 89 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99462920 |
| 90 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98002151 |
| 91 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.97824087 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97313447 |
| 93 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97067473 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97054799 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97032043 |
| 96 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.95689931 |
| 97 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95069052 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94370938 |
| 99 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.94240928 |
| 100 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92035316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003950_abnormal_plasma_membrane | 9.86892658 |
| 2 | MP0008961_abnormal_basal_metabolism | 5.01774505 |
| 3 | MP0002653_abnormal_ependyma_morphology | 4.51453109 |
| 4 | MP0004233_abnormal_muscle_weight | 4.20898816 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.83017566 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.15908618 |
| 7 | MP0005451_abnormal_body_composition | 3.14225104 |
| 8 | MP0003959_abnormal_lean_body | 2.91642304 |
| 9 | MP0005409_darkened_coat_color | 2.89894600 |
| 10 | MP0001346_abnormal_lacrimal_gland | 2.79498309 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.76470630 |
| 12 | MP0005623_abnormal_meninges_morphology | 2.57388733 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.17287841 |
| 14 | MP0003828_pulmonary_edema | 2.12261333 |
| 15 | MP0009384_cardiac_valve_regurgitation | 1.85126712 |
| 16 | MP0008438_abnormal_cutaneous_collagen | 1.74778133 |
| 17 | MP0000015_abnormal_ear_pigmentation | 1.73488133 |
| 18 | MP0000534_abnormal_ureter_morphology | 1.72096903 |
| 19 | MP0001188_hyperpigmentation | 1.54791330 |
| 20 | MP0003172_abnormal_lysosome_physiology | 1.51780137 |
| 21 | MP0003942_abnormal_urinary_system | 1.47074080 |
| 22 | MP0003303_peritoneal_inflammation | 1.45418371 |
| 23 | MP0009250_abnormal_appendicular_skeleto | 1.41101251 |
| 24 | MP0009278_abnormal_bone_marrow | 1.39100063 |
| 25 | MP0009840_abnormal_foam_cell | 1.36396370 |
| 26 | MP0004858_abnormal_nervous_system | 1.22816017 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.20197590 |
| 28 | MP0004185_abnormal_adipocyte_glucose | 1.19712130 |
| 29 | MP0005023_abnormal_wound_healing | 1.15995839 |
| 30 | MP0000678_abnormal_parathyroid_gland | 1.15680801 |
| 31 | MP0001849_ear_inflammation | 1.14604824 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.13530514 |
| 33 | MP0002896_abnormal_bone_mineralization | 1.06788566 |
| 34 | MP0000733_abnormal_muscle_development | 1.02612942 |
| 35 | MP0003436_decreased_susceptibility_to | 1.01122784 |
| 36 | MP0000767_abnormal_smooth_muscle | 0.93891383 |
| 37 | MP0001299_abnormal_eye_distance/ | 0.91197811 |
| 38 | MP0000858_altered_metastatic_potential | 0.90429620 |
| 39 | MP0001879_abnormal_lymphatic_vessel | 0.87385645 |
| 40 | MP0003091_abnormal_cell_migration | 0.86330613 |
| 41 | MP0003329_amyloid_beta_deposits | 0.86000769 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 0.85490154 |
| 43 | MP0000467_abnormal_esophagus_morphology | 0.84691074 |
| 44 | MP0001873_stomach_inflammation | 0.84259176 |
| 45 | MP0001958_emphysema | 0.82608009 |
| 46 | MP0000759_abnormal_skeletal_muscle | 0.82361770 |
| 47 | MP0006138_congestive_heart_failure | 0.80887285 |
| 48 | MP0005464_abnormal_platelet_physiology | 0.80784720 |
| 49 | MP0002249_abnormal_larynx_morphology | 0.80382663 |
| 50 | MP0003941_abnormal_skin_development | 0.78251830 |
| 51 | MP0008932_abnormal_embryonic_tissue | 0.77160699 |
| 52 | MP0008874_decreased_physiological_sensi | 0.75015386 |
| 53 | MP0002998_abnormal_bone_remodeling | 0.73726592 |
| 54 | MP0003566_abnormal_cell_adhesion | 0.70605758 |
| 55 | MP0004036_abnormal_muscle_relaxation | 0.69147551 |
| 56 | MP0001533_abnormal_skeleton_physiology | 0.68354503 |
| 57 | MP0005165_increased_susceptibility_to | 0.68178096 |
| 58 | MP0000685_abnormal_immune_system | 0.67072167 |
| 59 | MP0005076_abnormal_cell_differentiation | 0.66401015 |
| 60 | MP0004947_skin_inflammation | 0.65799866 |
| 61 | MP0001664_abnormal_digestion | 0.64915977 |
| 62 | MP0009672_abnormal_birth_weight | 0.63262884 |
| 63 | MP0000537_abnormal_urethra_morphology | 0.62999451 |
| 64 | MP0000490_abnormal_crypts_of | 0.62763509 |
| 65 | MP0003111_abnormal_nucleus_morphology | 0.61936768 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 0.60898499 |
| 67 | MP0003075_altered_response_to | 0.59738597 |
| 68 | MP0005595_abnormal_vascular_smooth | 0.58808746 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 0.58608391 |
| 70 | MP0002295_abnormal_pulmonary_circulatio | 0.57185320 |
| 71 | MP0000350_abnormal_cell_proliferation | 0.57019917 |
| 72 | MP0002089_abnormal_postnatal_growth/wei | 0.56068768 |
| 73 | MP0008057_abnormal_DNA_replication | 0.54509121 |
| 74 | MP0005390_skeleton_phenotype | 0.54367816 |
| 75 | MP0002102_abnormal_ear_morphology | 0.54235300 |
| 76 | MP0005508_abnormal_skeleton_morphology | 0.53654006 |
| 77 | MP0003763_abnormal_thymus_physiology | 0.53469762 |
| 78 | MP0004272_abnormal_basement_membrane | 0.52848884 |
| 79 | MP0008770_decreased_survivor_rate | 0.52842375 |
| 80 | MP0001663_abnormal_digestive_system | 0.52048661 |
| 81 | MP0005501_abnormal_skin_physiology | 0.51492603 |
| 82 | MP0010030_abnormal_orbit_morphology | 0.51266602 |
| 83 | MP0002127_abnormal_cardiovascular_syste | 0.51209830 |
| 84 | MP0002111_abnormal_tail_morphology | 0.50821066 |
| 85 | MP0002269_muscular_atrophy | 0.50653332 |
| 86 | MP0005187_abnormal_penis_morphology | 0.49893445 |
| 87 | MP0009053_abnormal_anal_canal | 0.49376091 |
| 88 | MP0001542_abnormal_bone_strength | 0.49192878 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 0.48677140 |
| 90 | MP0001545_abnormal_hematopoietic_system | 0.48677140 |
| 91 | MP0000749_muscle_degeneration | 0.48584707 |
| 92 | MP0002113_abnormal_skeleton_development | 0.48223030 |
| 93 | MP0002114_abnormal_axial_skeleton | 0.47507365 |
| 94 | MP0002080_prenatal_lethality | 0.47329902 |
| 95 | MP0001790_abnormal_immune_system | 0.47206720 |
| 96 | MP0005387_immune_system_phenotype | 0.47206720 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.46861415 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.46074675 |
| 99 | MP0001727_abnormal_embryo_implantation | 0.46039524 |
| 100 | MP0002405_respiratory_system_inflammati | 0.46013335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spinal rigidity (HP:0003306) | 5.88717064 |
| 2 | Muscle stiffness (HP:0003552) | 5.24446352 |
| 3 | Myotonia (HP:0002486) | 5.15545963 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.97928394 |
| 5 | IgA deficiency (HP:0002720) | 4.92320375 |
| 6 | Abnormality of carpal bone ossification (HP:0006257) | 4.89141601 |
| 7 | Genu recurvatum (HP:0002816) | 4.47573747 |
| 8 | Gastrointestinal dysmotility (HP:0002579) | 4.32239070 |
| 9 | Abnormal ossification of hand bones (HP:0005921) | 3.83917767 |
| 10 | Syringomyelia (HP:0003396) | 3.82985723 |
| 11 | Spinal cord lesions (HP:0100561) | 3.82985723 |
| 12 | Cervical subluxation (HP:0003308) | 3.82555515 |
| 13 | Prolonged QT interval (HP:0001657) | 3.82438784 |
| 14 | Relative macrocephaly (HP:0004482) | 3.75786044 |
| 15 | Cupped ribs (HP:0000887) | 3.72576881 |
| 16 | Abnormal hand bone ossification (HP:0010660) | 3.59398306 |
| 17 | Bradycardia (HP:0001662) | 3.53872681 |
| 18 | Patellar dislocation (HP:0002999) | 3.41193796 |
| 19 | Epiphyseal dysplasia (HP:0002656) | 3.39435711 |
| 20 | Acanthosis nigricans (HP:0000956) | 3.32121609 |
| 21 | Cortical dysplasia (HP:0002539) | 3.27143996 |
| 22 | Abnormal umbilical cord blood vessels (HP:0011403) | 3.20051493 |
| 23 | Single umbilical artery (HP:0001195) | 3.20051493 |
| 24 | Abnormality of the fetal cardiovascular system (HP:0010948) | 3.20051493 |
| 25 | Vertebral compression fractures (HP:0002953) | 3.16966004 |
| 26 | Flared iliac wings (HP:0002869) | 3.13993912 |
| 27 | Generalized muscle weakness (HP:0003324) | 3.09291072 |
| 28 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.08110809 |
| 29 | Spinal cord compression (HP:0002176) | 3.02262054 |
| 30 | Distal lower limb muscle weakness (HP:0009053) | 3.00092752 |
| 31 | Mesangial abnormality (HP:0001966) | 2.99399475 |
| 32 | Insulin resistance (HP:0000855) | 2.93015323 |
| 33 | Hypertriglyceridemia (HP:0002155) | 2.92227836 |
| 34 | Short clavicles (HP:0000894) | 2.91398669 |
| 35 | Arterial tortuosity (HP:0005116) | 2.64528226 |
| 36 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 2.57337588 |
| 37 | Back pain (HP:0003418) | 2.55533918 |
| 38 | Vascular tortuosity (HP:0004948) | 2.54887545 |
| 39 | Hypoplastic left heart (HP:0004383) | 2.54490800 |
| 40 | Spondylolisthesis (HP:0003302) | 2.49581033 |
| 41 | Abnormality of the pulmonary veins (HP:0011718) | 2.49115532 |
| 42 | Asymmetry of the thorax (HP:0001555) | 2.46326748 |
| 43 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.33976545 |
| 44 | Hyperparathyroidism (HP:0000843) | 2.24889193 |
| 45 | Thin bony cortex (HP:0002753) | 2.22888680 |
| 46 | Short nail (HP:0001799) | 2.22572773 |
| 47 | Abnormality of the umbilical cord (HP:0010881) | 2.22370372 |
| 48 | Peripheral hypomyelination (HP:0007182) | 2.20796117 |
| 49 | Ovoid vertebral bodies (HP:0003300) | 2.18754951 |
| 50 | Muscular dystrophy (HP:0003560) | 2.15267037 |
| 51 | Premature rupture of membranes (HP:0001788) | 2.15264887 |
| 52 | Aortic aneurysm (HP:0004942) | 2.14001358 |
| 53 | Delayed cranial suture closure (HP:0000270) | 2.10114905 |
| 54 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.09149816 |
| 55 | Blue sclerae (HP:0000592) | 2.09007268 |
| 56 | Abnormal gallbladder physiology (HP:0012438) | 2.07680029 |
| 57 | Cholecystitis (HP:0001082) | 2.07680029 |
| 58 | Hyperacusis (HP:0010780) | 2.07220823 |
| 59 | Zonular cataract (HP:0010920) | 2.04466337 |
| 60 | Atrial fibrillation (HP:0005110) | 2.04383542 |
| 61 | Bell-shaped thorax (HP:0001591) | 2.00803828 |
| 62 | Annular pancreas (HP:0001734) | 2.00129820 |
| 63 | Ileus (HP:0002595) | 10.5200136 |
| 64 | Distal lower limb amyotrophy (HP:0008944) | 1.98214617 |
| 65 | Coxa vara (HP:0002812) | 1.97385814 |
| 66 | Aneurysm (HP:0002617) | 1.94974400 |
| 67 | Mitral regurgitation (HP:0001653) | 1.93911254 |
| 68 | Osteopenia (HP:0000938) | 1.93028169 |
| 69 | Supraventricular tachycardia (HP:0004755) | 1.91518652 |
| 70 | Abnormality of the acetabulum (HP:0003170) | 1.87034426 |
| 71 | Hypoplastic heart (HP:0001961) | 1.85558177 |
| 72 | Hypoventilation (HP:0002791) | 1.84790685 |
| 73 | Supraventricular arrhythmia (HP:0005115) | 1.84587211 |
| 74 | Abnormal EKG (HP:0003115) | 1.84454169 |
| 75 | Biconcave vertebral bodies (HP:0004586) | 1.84232647 |
| 76 | Primary atrial arrhythmia (HP:0001692) | 1.84177404 |
| 77 | Abnormality of dentin (HP:0010299) | 1.83548790 |
| 78 | Buphthalmos (HP:0000557) | 1.83467837 |
| 79 | Joint stiffness (HP:0001387) | 1.81818807 |
| 80 | Flared metaphyses (HP:0003015) | 1.80123937 |
| 81 | Hydroureter (HP:0000072) | 1.79389365 |
| 82 | Skin nodule (HP:0200036) | 1.79199847 |
| 83 | Joint laxity (HP:0001388) | 1.77963164 |
| 84 | Insomnia (HP:0100785) | 1.75031053 |
| 85 | Broad phalanx (HP:0006009) | 1.74377479 |
| 86 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74187970 |
| 87 | Broad long bones (HP:0005622) | 1.72040511 |
| 88 | Flat face (HP:0012368) | 1.71810902 |
| 89 | Dysostosis multiplex (HP:0000943) | 1.71781430 |
| 90 | Multiple lipomas (HP:0001012) | 1.71576503 |
| 91 | Hirsutism (HP:0001007) | 1.71014486 |
| 92 | Hypertensive crisis (HP:0100735) | 1.67113069 |
| 93 | Loss of speech (HP:0002371) | 1.66119068 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.65675822 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.65675822 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.65675822 |
| 97 | Broad metatarsal (HP:0001783) | 1.65443480 |
| 98 | Congenital glaucoma (HP:0001087) | 1.63984458 |
| 99 | Mucopolysacchariduria (HP:0008155) | 1.62655405 |
| 100 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.62655405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK10 | 7.37414018 |
| 2 | LRRK2 | 5.46219561 |
| 3 | TRIB3 | 4.36374553 |
| 4 | DDR2 | 3.37940346 |
| 5 | PNCK | 3.16824880 |
| 6 | VRK2 | 3.15572766 |
| 7 | PKN2 | 2.92998892 |
| 8 | CAMK1G | 2.48673522 |
| 9 | MAP3K8 | 2.37732448 |
| 10 | ROCK2 | 2.23657382 |
| 11 | RIPK1 | 2.00242018 |
| 12 | EEF2K | 1.99932780 |
| 13 | ERN1 | 1.86795189 |
| 14 | EIF2AK1 | 1.78717448 |
| 15 | CDK8 | 1.77427900 |
| 16 | ADRBK1 | 1.67903797 |
| 17 | PRKG2 | 1.62136269 |
| 18 | PIM2 | 1.61973697 |
| 19 | NTRK1 | 1.42597427 |
| 20 | PAK4 | 1.35654381 |
| 21 | SMG1 | 1.31529334 |
| 22 | ROCK1 | 1.30657117 |
| 23 | PRKD2 | 1.27622018 |
| 24 | CAMK1 | 1.21138323 |
| 25 | CAMK4 | 1.11242368 |
| 26 | PRPF4B | 1.10373014 |
| 27 | PRKD3 | 1.04656171 |
| 28 | TESK1 | 1.01117106 |
| 29 | MTOR | 1.00767982 |
| 30 | MARK2 | 0.97852137 |
| 31 | ARAF | 0.97344674 |
| 32 | WNK1 | 0.97306730 |
| 33 | MAP3K10 | 0.95891842 |
| 34 | MAP2K3 | 0.95527164 |
| 35 | STK16 | 0.92282892 |
| 36 | PDGFRA | 0.91308686 |
| 37 | PRKCQ | 0.85549400 |
| 38 | MAP3K13 | 0.84511405 |
| 39 | MAPKAPK3 | 0.81564952 |
| 40 | IRAK3 | 0.80171202 |
| 41 | MELK | 0.78871554 |
| 42 | NME2 | 0.78498164 |
| 43 | WNK4 | 0.76987245 |
| 44 | CDK4 | 0.74837023 |
| 45 | PDGFRB | 0.72407029 |
| 46 | ALK | 0.71430625 |
| 47 | TESK2 | 0.67895461 |
| 48 | CDK9 | 0.67265823 |
| 49 | MAP3K3 | 0.66713236 |
| 50 | PAK6 | 0.64527504 |
| 51 | PTK2 | 0.62733224 |
| 52 | TAOK2 | 0.62560233 |
| 53 | TBK1 | 0.61157451 |
| 54 | PRKCZ | 0.59724491 |
| 55 | CAMKK1 | 0.56181608 |
| 56 | CAMK1D | 0.55706124 |
| 57 | AURKB | 0.53919843 |
| 58 | EPHB2 | 0.52521039 |
| 59 | PAK1 | 0.52063914 |
| 60 | ICK | 0.50581084 |
| 61 | CDC42BPA | 0.49738587 |
| 62 | MAP2K1 | 0.48716486 |
| 63 | PAK2 | 0.44813504 |
| 64 | KSR2 | 0.44364618 |
| 65 | MAP3K11 | 0.43683779 |
| 66 | ZAP70 | 0.43622862 |
| 67 | EPHB1 | 0.43147813 |
| 68 | MAP3K7 | 0.40324361 |
| 69 | STK38 | 0.39415841 |
| 70 | MAP2K2 | 0.39305288 |
| 71 | GRK6 | 0.38490098 |
| 72 | CAMK2G | 0.37336831 |
| 73 | CDK7 | 0.37283978 |
| 74 | MOS | 0.36215123 |
| 75 | ILK | 0.34579991 |
| 76 | SRPK1 | 0.34419748 |
| 77 | PTK6 | 0.32932117 |
| 78 | MAP4K1 | 0.31871118 |
| 79 | AKT3 | 0.30257037 |
| 80 | RPS6KA2 | 0.29825924 |
| 81 | MAP3K5 | 0.28246461 |
| 82 | FES | 0.28171609 |
| 83 | TAOK1 | 0.27328316 |
| 84 | TYRO3 | 0.27232090 |
| 85 | DAPK3 | 0.27153545 |
| 86 | MYLK | 0.26592748 |
| 87 | MAPK11 | 0.26242102 |
| 88 | ABL2 | 0.26022538 |
| 89 | TAF1 | 0.25997912 |
| 90 | PRKD1 | 0.25771080 |
| 91 | PRKACG | 0.25747371 |
| 92 | PDPK1 | 0.24621968 |
| 93 | SGK3 | 0.24591143 |
| 94 | CDK3 | 0.24571179 |
| 95 | SIK1 | 0.24448049 |
| 96 | MAPKAPK5 | 0.24273812 |
| 97 | RPS6KA1 | 0.23303078 |
| 98 | EPHA2 | 0.22583121 |
| 99 | BRAF | 0.21711672 |
| 100 | AURKA | 0.20935341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 5.15732100 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 5.09059318 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 4.24941294 |
| 4 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 3.44509591 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.76480900 |
| 6 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.03128514 |
| 7 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.83088451 |
| 8 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.61085914 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.55505595 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 1.53956380 |
| 11 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.52983387 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45357861 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42746916 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42416896 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41177202 |
| 16 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.41047171 |
| 17 | Glioma_Homo sapiens_hsa05214 | 1.37096844 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.33457666 |
| 19 | Endocytosis_Homo sapiens_hsa04144 | 1.27579499 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.23440368 |
| 21 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.22580202 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.21912754 |
| 23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19101321 |
| 24 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.18142658 |
| 25 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.17826579 |
| 26 | Prostate cancer_Homo sapiens_hsa05215 | 1.14484611 |
| 27 | Bladder cancer_Homo sapiens_hsa05219 | 1.09975796 |
| 28 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08779184 |
| 29 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.06685128 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 1.05704497 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05011017 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01801326 |
| 33 | Endometrial cancer_Homo sapiens_hsa05213 | 1.01063232 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95999145 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 0.94483304 |
| 36 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.94399692 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 0.93022671 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92811143 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92062984 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91898557 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90798162 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89402265 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 0.84399264 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83452267 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.82872126 |
| 46 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79763667 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78884001 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78199664 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76785043 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75853070 |
| 51 | Adherens junction_Homo sapiens_hsa04520 | 0.73384339 |
| 52 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.71771574 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.70967715 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 0.70354454 |
| 55 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69365238 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.67854089 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67565846 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64661119 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.64535756 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.63397623 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63324165 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.63296220 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62950195 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61562908 |
| 65 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61499267 |
| 66 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60611567 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59936006 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59863114 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59190562 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57621780 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56478153 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55757604 |
| 73 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55484708 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55377102 |
| 75 | Melanoma_Homo sapiens_hsa05218 | 0.55090313 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54513177 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52072862 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.51835427 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51342444 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49872277 |
| 81 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48936184 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48462108 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48170986 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47933387 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47828011 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47506726 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47403637 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45860216 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44674710 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.43145796 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42407484 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40735343 |
| 93 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40179938 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38659340 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38190304 |
| 96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37905713 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36523302 |
| 98 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.36299811 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36130031 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35168278 |

